A Pfizer representative contacted the editorial office to raise concerns that there are image duplications in this article. Pfizer has undertaken a review and determined that there are duplications in Fig 4A of the article and that part of the experiments cannot be verified.
In light of the concerns identified, the authors and the PLOS ONE Editors retract this article. We did not receive any comments from Min-Jean Yin, Rounak Nassirpour or Pramod Mehta.
Reference
- 1. Nassirpour R, Mehta PP, Yin M-J (2013) miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3. PLoS ONE 8(11): e79655. https://doi.org/10.1371/journal.pone.0079655 pmid:24244539
Citation: The PLOS ONE Editors (2017) Retraction: miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3. PLoS ONE 12(9): e0184778. https://doi.org/10.1371/journal.pone.0184778
Published: September 8, 2017
Copyright: © 2017 The PLOS ONE Editors. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.